Pro Medicus Limited (ASX: PME) shares are rising on Monday morning.
At the time of writing, the ASX 200 tech stock is up 1% to $258.00.
This has been driven by the release of another positive announcement.
This morning, the leading health imaging company announced its fourth major contract win in just over a month.
As readers may be aware, at the end of November, the ASX 200 tech stock announced a $24 million deal with NYU Langone Health and a massive $330 million deal with Trinity Health. It then followed this up with the signing of a $30 million deal with Duly Health and Care last week.
Today the company has announced another win. And while it is the smallest of the four, it is with an existing client and is a transaction-based model with potential upside.
According to the release, the ASX 200 tech stock has signed an additional $15 million, five-year contract with Duke University Health System. It is a leading North American academic medical centre.
The release notes that the contract, which is based on a transaction-based licensing model, will see the Visage 7 Open Archive supplement the existing Visage 7 Viewer contract signed with Duke University Health System in May 2019.
Visage 7 Open Archive is a native, optional module of Visage 7. The company notes that it is designed for optimal interoperability, excelling in modular, multi-system, multi-vendor environments by enabling efficient workflows, integration, and consolidation of disparate systems.
As part of the deal, Duke's current on-premise instance of Visage will be deployed to the cloud along with Visage 7 Open archive. The Visage 7 Viewer contract has been extended for a further two years to the end of 2029, as part of the deal.
Pro Medicus advised that planning for the rollout is to commence immediately and will involve the migration of Duke University Health System's current archive to the Visage 7 Open Archive.
The ASX 200 tech stock's CEO, Dr Sam Hupert, was pleased with the deal and believes it is another positive sign for the future. He said:
This deal that confirms our belief that there is a material opportunity for us to sell Visage 7 Open Archive to our existing base of "viewer only" clients. Not only does this provide clients with a highly performant, highly scalable solution, it is a key step in facilitating their transition from on-premise to cloud, a trend we see continuing.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。